<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03467919</url>
  </required_header>
  <id_info>
    <org_study_id>41688</org_study_id>
    <nct_id>NCT03467919</nct_id>
  </id_info>
  <brief_title>Adipose-Derived Stem Cell Injections for Knee Osteoarthritis</brief_title>
  <official_title>The Effect of Adipose-Derived Stem Cell With Platelet-Rich Plasma Injections on Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-surgical trial comparing the clinical and functional outcomes of patients with
      osteoarthritis treated with Intra-articular injection of autologous Adipose-Derived Stem
      Cells (ADSC) combined with platelet-rich plasma (PRP) versus conventional therapy of
      Intra-articular injection of corticosteroid.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a randomized controlled trial to compare outcomes between intra-articular
      injection of ADSC+PRP and intra-articular injection of corticosteroid in patients with mild
      to moderate osteoarthritis of the knee. ADSC will be harvested at the subcutaneous tissue by
      lipoaspiration. Once fat tissue is obtained, it will be processed with minimal manipulation
      (Adiprep) in the clinic room.

      PRP is prepped from the peripheral blood. Up to 30 ml of peripheral blood is drawn from the
      peripheral blood vessel then it is transferred to the tube for centrifugation to yield a
      platelet-rich plasma layer. This process is expected to take up to 1 hour.

      To be considered for participation in this study, patients must have radiographic evidence of
      mild to moderate osteoarthritis of medial and/or lateral weight-bearing compartments
      (Kellgren-Lawrence Grade 2 or 3).

      In addition, patients must meet several inclusion/exclusion criteria to be randomized and
      included in this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Injury and Osteoarthritis Outcomes Score (KOOS) Score</measure>
    <time_frame>24 months</time_frame>
    <description>Patient reported outcome measure that reports a normalized score (100 indicating no symptoms and 0 indicating extreme symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lysholm score</measure>
    <time_frame>24 months</time_frame>
    <description>Patient reported activity outcome measure on a scale of 0-100 (100 is best activity score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Veterans RAND 12 (VR-12) score</measure>
    <time_frame>24 months</time_frame>
    <description>Patient reported quality of life outcome measure on a scale of 0-50 with 50 being healthy</description>
  </secondary_outcome>
  <other_outcome>
    <measure>MRI Cartilage Scan</measure>
    <time_frame>24 months</time_frame>
    <description>Cartilage thickness on MRI using T2-weighted cartilage mapping</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Knee Pain</condition>
  <arm_group>
    <arm_group_label>Stem Cells (with PRP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-articular knee injection of autologous Adipose-Derived Mesenchymal Stem Cells (ADSC) harvested from the thigh using tumescent liposuction and processing with syringe emulsification and cell concentration using Harvest Adiprep System. This harvested tissue will then be combined with leukocyte poor-platelet-rich plasma (PRP) processed using the Harvest PRP system and then injected into the patient's knee.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-articular injection of corticosteroid (Triamcinolone 40mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stem Cell injection</intervention_name>
    <description>Harvesting of adipose-derived stem cells and platelet-rich plasma with intra-articular injection</description>
    <arm_group_label>Stem Cells (with PRP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid injection</intervention_name>
    <description>Sham harvesting of adipose tissue and peripheral blood without intra-articular injection. Intra-articular injection of corticosteroid</description>
    <arm_group_label>Conventional therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 35 and 75 years-old

          -  Diagnosis of pre-existing osteoarthritis of the joint by Kellgren-Lawrence Grade 2 or
             3.

          -  Working understanding of the English language and able to fully understand the
             procedure

          -  Capable of providing informed consent

          -  Able to complete online, in-person or phone surveys for the purposes of follow-up

          -  Capable of understanding pre- and post-procedure care instructions

          -  Ambulatory at baseline

          -  Previous trial and failure of conservative therapy consisting of a minimum of 6 weeks
             of physical therapy and trial of anti-inflammatory medications if not contraindicated,
             with or without concomitant bracing and/or injections.

        Exclusion Criteria:

          -  Age &lt; 35 or &gt; 75 years old

          -  Radiographs demonstrating either no, little or severe osteoarthritis
             (Kellgren-Lawrence Grade 0, 1 )

          -  Prior total or partial joint replacement surgery or a surgery involving cartilage
             regeneration (microfracture, ACI, etc)

          -  Previous cortisone and/or Hyaluronic acid intra-articular injection within the last 3
             months

          -  Co-morbidity with rheumatologic condition, inflammatory arthritis

          -  Currently undergoing immunomodulatory therapy

          -  Uncontrolled endocrine disorder

          -  BMI &gt;35

          -  Current diagnosis of osteomyelitis, human immunodeficiency virus (HIV-1, -2) and/or
             hepatitis C (HCV), infection and poorly controlled diabetes (HgA1C &gt;7.0)

          -  Pregnancy or planned pregnancy

          -  previous stem cell injection into treatment joint

          -  Patient scheduled to undergo any concomitant surgical procedures.

          -  Coagulopathy or anticoagulant treatment

          -  Chronic pain involving multiple body parts or opioid medication management
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason L Dragoo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eugene Y Roh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrian DK Le, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michelle Backer, BS</last_name>
    <phone>(650) 721-7653</phone>
    <email>mbacker@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason L Dragoo, MD</last_name>
      <email>mbacker@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Jason L Dragoo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eugene Y Roh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrian DK Le, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2018</study_first_posted>
  <last_update_submitted>March 10, 2018</last_update_submitted>
  <last_update_submitted_qc>March 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Jason L. Dragoo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>osteoarthritis</keyword>
  <keyword>stem cell</keyword>
  <keyword>knee pain</keyword>
  <keyword>adipose derived stem cell</keyword>
  <keyword>injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

